Françoise Bouet-Toussaint

Vγ9Vδ2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas

Françoise Bouet-Toussaint, Florian Cabillic, Olivier Toutirais et al. · Cancer Immunology Immunotherapy · 2007 · 104 citations · Full text

Human Solid Tumors, Cancer Immunosurveillance, Immunology +9

Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients

Florian Cabillic, Olivier Toutirais, Vincent Lavoué et al. · Cancer Immunology Immunotherapy · 2010 · 68 citations · Full text

Cancer Immunosurveillance, Advanced Cancer Patients, Immunology +10

Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency

Alban Gervais, Jean Lévêque, Françoise Bouet-Toussaint et al. · Breast Cancer Research · 2005 · 53 citations · Full text

Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte–dendritic cell cross-talk

Florian Cabillic, Françoise Bouet-Toussaint, Olivier Toutirais et al. · Clinical & Experimental Immunology · 2006 · 35 citations · Full text

Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: Implications for immunotherapy

Vincent Lavoué, Florian Cabillic, Olivier Toutirais et al. · International Journal of Cancer · 2011 · 16 citations · Full text

Lymphocyte Development, Epithelial Ovarian Cancer, Immunology +22